dr.dosingreferenceResearch Reference
← All articles
Timeline

Selank timeline: what research and user reports show

Selank is a synthetic anxiolytic peptide developed from a fragment of tuftsin, and like Semax, its most commonly reported effects are acute rather than something requiring a long buildup.

Not usage instructions. This is a summary of published research and publicly reported research community experience. It is not a protocol, not medical advice and not a recommendation to start, stop or adjust anything.

Same day: acute reports

A calmer, less anxious feeling within hours of intranasal use is the most commonly reported pattern, generally described as milder and less sedating than conventional anxiolytic medications.

Weeks 1 to a few: cumulative use

With regular use over one to a few weeks, reports increasingly describe more stable mood and stress resilience, though the acute per-dose effect remains the most consistently reported one.

Common questions

How is this different from Semax? Both are Russian-developed peptides with acute nootropic or anxiolytic effects, but Selank is generally reported as more calming and Semax more focus-oriented.

For mechanism, dosing reference and citations, see the Selank reference page.

Putting this into practice? Browse the compound references or run your numbers in the dosage calculator.
Important. For research and educational use only. Not medical advice. Compounds referenced are for research use only and not for human consumption.